跳至主要内容
临床试验/NCT05008185
NCT05008185招募中不适用

Regenerative Peripheral Nerve Interfaces to Treat Painful Digit and Hand Neuromas After Amputation: A Prospective Observational Trial"

Medstar Health Research Institute2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2021年10月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
80
试验地点
2
主要终点
Patient-Reported Outcomes Measurement Information System - Pain Interference (PROMIS-PI)

研究概览

简要总结

This study is being done to demonstrate the effectiveness of Regenerative Peripheral Nerve Interfaces (RPNI) surgery in treating symptomatic neuromas of the hand and digits following amputation compared to standard of care using a Prospective, Observational Trial

详细描述

This will be a prospective observational study that seeks to provide a comprehensive assessment of the outcomes after RPNI surgery compared to standard of care by utilizing multiple established and validated patient-reported outcomes measures, carefully tracking pre- and post-operative pain regimens, and performing functional and physiologic tests.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • History of unilateral digit, multiple digit, or partial hand amputation
  • Discrete neuroma pain on clinical exam
  • Following standard of care (SOC), confirmation through a local block and/or ultrasound imaging will be performed if indicated
  • Must be seen by a hand therapist for at least 6-week trial of desensitization therapy

排除标准

  • Patients with previous surgical treatment for symptomatic neuromas of the digits or hand
  • Patients with other major injuries more proximal in the ipsilateral extremity that cause chronic pain or functional loss
  • women pregnant at time of enrollment
  • prisoners
  • adults who are unable to consent

结局指标

主要结局

Patient-Reported Outcomes Measurement Information System - Pain Interference (PROMIS-PI)

时间窗: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months

PROMIS Pain Interference (PROMIS-PI) scale measures the extent to which pain hinders an individual's engagement with physical, mental, cognitive, emotional, recreational, and social activities over the past 7 days answering each questions with a response of not at all, a little bit, somewhat, quite a bit, and very much with not at all being the best and very much the worst.

Short-form McGill Pain Questionnaire (SF-MPQ-2)

时间窗: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months

theShort-form McGill Pain Questionnaire (SF-MPQ-2) measures 24 different qualities of pain and related symptoms using the intensity of pain and related symptoms felt during the past week on 0 to 10 scale, with 0 being no pain and 10 being the worst pain .

PROMIS Global Health (GH) v1.2

时间窗: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months

The Global Health Questionnaire contains 10 questions (7 general and 3 about the last 7 days). First 7 questions use a scale of excellent, very good, good, fair, and poor, poor being the worst with excellent being the best. The other three questions use different scales such as; never rarely, sometimes, often or always with never being the best and always being the worst; as well as none, mild, moderate, severe, very severe with none being the best and very severe being the worst; finally pain rating numbered 0-10 with 0 being no pain and 10 being the worst pain imaginable.

Patient Health Questionnaire (PHQ-9),

时间窗: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months

The PHQ-9 form is a brief, self-administered questionnaire that assesses depression symptoms over the last 2 weeks consisting of 10 questions. 9 will be answered on a scale of 0-3 with 0 being the best and 3 bing the worst. The last question will use a response of not difficult at all, somewhat difficult, very difficult, and extremely difficult with not difficult at all being the best and extremely difficult being the worst.

Generalized Anxiety Disorder measure (GAD-7),

时间窗: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months

Generalized Anxiety Disorder measure (GAD-7) is a screening tool and severity measure for generalised anxiety disorder (GAD) over the past 2 weeks consisting of 7 questions answered on a scale of 0-3 with 0 being the best and 3 being the worst.

PC-PTSD-5

时间窗: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months

The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) is a 5-item screening tool with 'Yes/No" answers designed to identify individuals with probable PTSD. Yes" answers represent the worst and "no" represents the best.

次要结局

  • PROMIS UpperExtremity (UE)(Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months)
  • Brief Michigan Hand Outcomes Questionnaire (bMHQ)(Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months)
  • Grip Strength(Assessing change from Baseline to 1 month, 3 months and 6 months)
  • Pinch Strength -Key and Three-point(Assessing change from Baseline to 1 month, 3 months and 6 months)
  • Range of Motion(Assessing change from Baseline to 1 month, 3 months and 6 months)
  • Fine Motor Function - 9-Hole Peg Test (9HPT)(Assessing change from Baseline to 1 month, 3 months and 6 months)
  • FunctionalTask Testing - Lifting boxes(Assessing change from Baseline to 1 month, 3 months and 6 months)
  • Functional Task Testing - Carrying Boxes(Assessing change from Baseline to 1 month, 3 months and 6 months)
  • Functional Task Testing - Push/Pull sled(Assessing change from Baseline to 1 month, 3 months and 6 months)
  • Functional Task Testing - Hammer(Assessing change from Baseline to 1 month, 3 months and 6 months)
  • Functional Task Testing - Vice Grip(Assessing change from Baseline to 1 month, 3 months and 6 months)
  • Functional Task Testing - Gear Shifting(Assessing change from Baseline to 1 month, 3 months and 6 months)
  • Functional Task Testing - Weapon Recoil(Assessing change from Baseline to 1 month, 3 months and 6 months)

研究者

发起方
Medstar Health Research Institute
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验